FDA ivermectin

The Independent Medical Alliance is proud to congratulate Dr. Mary Talley Bowden on being recognized for her frontline medical service in the Lone Star state.

The FDA has complied with the March 22 settlement, removed, and replaced the page on their website, and deleted social media posts that erroneously attempted to say that ivermectin was for horses.

A settlement has been reached between the Food and Drug Administration (FDA) and the plaintiffs in a groundbreaking case filed in federal court to decide if the FDA violated its authority as a federal health agency in telling the public to stop taking ivermectin, a safe, well-studied, and proven drug for the prevention and treatment of COVID-19.

Debra had previously worked for a pediatrician and was very familiar with ivermectin so when the horse-paste propaganda was spread she and her husband both knew that it wasn’t true.

Rather than acknowledging the alarming, unprecedented spike in adverse events since the COVID jab rollout, the FDA spin job features VAERS “success stories.”

Dr. Pierre Kory returns to the Ask Dr. Drew show and gives his take on the global cost of the FDA's smears against the Nobel Prize-winning drug.

Dr. Kory exposes “misleading” claims from the FDA and CDC about Ivermectin and Hydroxychloroquine, ‘sovereign immunity’ and the impact of denying care to patients during the pandemic.

Dr. Pierre Kory gives his take on the global cost of the FDA's smears against the Nobel Prize-winning drug.

Dr. Pierre Kory returns to The Absolute Truth with Emerald Robinson to discuss a federal appellate court ruling on the FDA-Ivermectin lawsuit.

The Fifth Circuit Court of Appeals reversed a lower court's ruling that “sovereign immunity” protects the Food and Drug Administration (FDA) from any wrongdoing or harm in telling the public to stop taking ivermectin.

“We are very pleased with this development and extremely proud of our colleagues for taking a stand against a government health agency that is clearly overstepping its authority,” said Pierre Kory, M.D.

The FLCCC filed its amicus brief yesterday in support of the lawsuit against the U.S. Department of Health and Human Services (DHHS) for the agency’s campaign against prescribing ivermectin that denied countless patients access to a safe and potentially lifesaving treatment for COVID-19.

Judge Dismisses Lawsuit Against FDA for Disparaging ivermectin as COVID-19 Treatment, but the plaintiffs, including FLCCC's Dr. Paul Marik, plan to appeal.

Dr. Marik, Dr. Kory and the FLCCC Alliance are cited in this long-form French media report on the struggle for medical freedom and repurposed drugs -- in the United States.

This week's FLCCC News Capsule covers an incredible roundtable in D.C., new testimonials, news updates, and an information-packed weekly webinar.

The Association of American Physicians and Surgeons (AAPS) filed a motion and amicus brief Thursday evening with the federal district court in Galveston urging it to allow a lawsuit to proceed against the Food & Drug Administration (FDA) for its misleading statements against ivermectin.

A lawsuit has been filed against the Department of Health and Human Services by Drs. Robert Apter, Mary Talley Bowden and the FLCCC’s Chief Scientific Officer, Dr. Paul Marik. The plaintiffs argue that the FDA acted outside of its authority and illegally interfered with their ability to practice medicine by directing the public, including health professionals and patients, to not use ivermectin, a drug that has received full FDA approval for human use.